The Dawn of Physical AI: Why Smart Matter is the Next Industrial Frontier

LONDON – June 02, 2026 – The line between hardware and software, between inert object and intelligent agent, is beginning to dissolve. A London-based startup named morph has emerged from stealth with a proposition that sounds like science fiction but is rooted in deep engineering: a platform that designs and manufactures “soft robotic cells.” These are not robots in the traditional sense of metal arms and whirring gears. Instead, think of materials that can sense their environment, adapt their shape, and change their stiffness in real time.

Founded by Dr. Jean Nehme, a former surgeon who previously built and sold a surgical AI company to Medtronic, morph is pioneering what it calls Physical AI. It’s a concept that moves intelligence from the cloud or a silicon chip into the very fabric of the products we use. This isn't just about making things “smart” by connecting them to the internet; it’s about rebuilding our physical world from the ground up with materials that are inherently responsive. The launch represents a critical inflection point, moving AI from a purely digital advisor to an active, physical participant in our world.

Unpacking Embodied Intelligence

For decades, the field of robotics has been dominated by rigid, powerful machines designed for precision and repetition in controlled environments. The emerging field of soft robotics, inspired by the flexible and adaptive forms of nature, offers a different path. Yet, much of the innovation has remained confined to academic labs, producing novelties like shape-shifting gels and robots with detachable limbs. morph’s ambition is to productize this research through a scalable platform.

The company’s core innovation is the “soft robotic cell,” a modular unit of synthetic material that embeds sensing, computation, and actuation. By configuring these cells into larger structures, a product—be it a shoe, a car seat, or a medical brace—can achieve complex behaviors. It can sense the pressure of a runner’s foot and stiffen a midsole for better energy return, or detect a driver’s posture and adjust seating for optimal ergonomic support over a long journey. This is the essence of Physical AI: intelligence built directly into a system that can take physical action.

“We have designed and built a very rigid and static world, but since the beginning nature has shown us softness and dynamism,” said Dr. Jean Nehme in the company's launch announcement. His statement cuts to the core of the industrial paradigm morph seeks to upend. While the company's claim to be the “world’s first” is a bold marketing stroke in a field rife with academic activity, its focus on creating a commercial platform to design and fabricate these systems is what sets it apart. It aims to provide the foundational engine for other companies to build a new generation of adaptive products.

A Surgeon's Blueprint for a Softer World

To understand the “why” behind morph, one must look at its founder. Dr. Jean Nehme is not a typical robotics engineer. His background as a reconstructive surgeon gave him an intimate, hands-on understanding of the human body’s remarkable properties—its softness, resilience, and inherent intelligence. He has seen firsthand how small biomechanical inefficiencies can compound over a lifetime, leading to chronic pain and degraded mobility. This clinical perspective is the philosophical bedrock of the company.

His vision is further sharpened by his proven track record in the business of AI. Dr. Nehme previously founded Digital Surgery, a company that pioneered the use of AI and data analytics in the operating room. Its acquisition by medical technology giant Medtronic in 2020 was a major validation of his ability to translate complex technology into high-stakes, real-world applications. This history lends significant credibility to morph's ambitious mission. It suggests a leader who understands not only the biological inspiration but also the disciplined execution required to build a deep-tech venture. His journey from mending human tissue to designing intelligent materials represents a powerful fusion of medicine and engineering, aiming to build a world that better accommodates the soft, dynamic nature of human biology.

The Smart Money Bets on Smart Materials

The vision has attracted a diverse and strategic coalition of investors. The presence of 8VC, a venture firm known for backing foundational, industry-transforming companies, signals that a key player in the deep-tech ecosystem sees morph not as a gadget-maker, but as a potential platform on which new industries will be built. This aligns with a market for soft robotics projected to grow from under $2 billion in 2024 to nearly $20 billion by 2033, indicating a massive economic shift is already underway.

Equally telling is the investment from Harvey Spevak, Chairman of Equinox Group, and celebrity innovator Pharrell Williams. Spevak’s backing is a powerful endorsement of morph’s initial go-to-market strategy, which targets human performance, injury prevention, and longevity. It suggests a clear and immediate application within the lucrative high-performance wellness and athletics markets. Williams’ involvement points to the technology’s potential to cross over into consumer culture, embedding adaptive technology into fashion and everyday lifestyle products. This blend of deep-tech, industry-specific, and cultural capital gives morph a unique strategic advantage, suggesting its technology could permeate society on multiple fronts simultaneously.

From Lab to Life: The Path to Commercialization

morph is not planning to build its own branded running shoes or car seats. Instead, it is pursuing a B2B strategy, positioning itself as a software, design, and fabrication partner for established industry leaders. The goal is to become the “Intel Inside” for the coming era of physical AI, enabling other companies with its core technology.

However, the path from a revolutionary platform to mass-market adoption is fraught with systemic challenges. The first hurdle is manufacturing. Scaling the production of complex, durable, and cost-effective deformable materials with integrated intelligence is a monumental task that has stymied many novel material companies. Second, the durability of these soft, active products must be proven, especially in applications involving constant stress and human interaction.

Finally, as morph looks beyond performance and into sectors like healthcare and automotive, it will face a gauntlet of regulatory hurdles and long development cycles. Gaining approval for a medical device with adaptive properties or integrating a shapeshifting safety component into a vehicle requires years of rigorous testing and validation. Success will depend not only on technological brilliance but also on navigating the complex ecosystems of its target industries, building trust, and demonstrating an undeniable value proposition that justifies the disruptive shift from static to dynamic systems.